Human Placenta Hydrolysates: From V.P. Filatov to the Present Day: Review

    March 2022 in “ Terapevticheskii arkhiv
    О. А. Громова, I. Yu. Torshin, А. Г. Чучалин, Valeriy Maximov
    TLDR Human placenta hydrolysates help treat various diseases and aid healing.
    The review highlighted the foundational work of V.P. Filatov in the study and clinical application of human placenta hydrolysates (HPH), with over 5,000 publications on the topic by 2022. Modern proteomics has advanced the understanding of HPH's peptide composition, suggesting complex molecular mechanisms in treating various conditions. The review discussed HPH's effects on liver diseases, atopic dermatitis, viral infections (including herpes, COVID-19, and viral hepatitis), iron overload, and chronic fatigue syndrome. Additionally, HPH was noted for its regenerative capabilities, enhancing wound healing and treating joint and reproductive system diseases.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 1000+ results

    Similar Research

    5 / 1000+ results